Investing

Safety Shot launching clinical trial to measure effect of its drink on blood alcohol levels

Safety Shot Inc.’s stock SHOT was down 5% in in premarket trading on Friday after the company said it started a clinical trial to measure the effects of its Safety Shot drink on blood and breath alcohol. The product is designed as a nutraceutical functional beverage that accelerates the body’s breakdown of alcohol while aiding in recovery and rehydration, the company said. The study includes a double-blinded placebo-controlled test in 36 participants to measure the amount of alcohol in the blood and breath, together with indices of alcohol effects. The company said it plans to launch business-to-business sales of Safety…

Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

Log In

Read the full article here

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

News

Introduction One of the interesting elements of preferred shares in Canada is that some of the issues (and then predominantly preferred equity issued by...

Copyright © 2023 Repay Down. All Rights Reserved.

Exit mobile version